adrenergic alpha-1 receptor antagonists

Preferred Label : adrenergic alpha-1 receptor antagonists;

MeSH definition : Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.;

MeSH synonym : adrenergic alpha1-Antagonists; adrenergic alpha1 antagonists; alpha1-Antagonists, adrenergic; alpha-1 adrenergic blocking agents; alpha 1 adrenergic blocking agents; alpha1-Adrenoceptor blocker; alpha1 adrenoceptor blocker; adrenergic alpha-1 antagonists; adrenergic alpha 1 antagonists; alpha-1 antagonists, adrenergic; adrenergic alpha-1 receptor blockers; adrenergic alpha 1 receptor blockers; adrenergic alpha 1 receptor antagonists; alpha1-Adrenergic Antagonists; Antagonists, alpha1-Adrenergic; alpha1 Adrenergic Antagonists;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058668;

UMLS CUI

C0304512;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Alpha-1 adrenergic receptor antagonist (disposition) [SNOMED CT concept]
- alpha 1 adrenergic blocking agent, nos [SNOMED Notion]
CISMeF manual mappings
- Product containing alpha-1 adrenergic receptor antagonist (product) [SNOMED CT concept]
- Substance with alpha-1 adrenergic receptor antagonist mechanism of action (substance) [SNOMED CT concept]
Indexing information
- 3-(4-(ethylthio)-1H-benzimidazol-2-yl)isoquinoline [MeSH Supplementary Concept]
- 7-((4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)thio)-4-methyl-2H-chromen-2-one [MeSH Supplementary Concept]
- 7-(2-hydroxypropoxy)-3,4-dihydroisoquinolin-1(2H)-one [MeSH Supplementary Concept]
- AdTx1 peptide, dendroaspis angusticep [MeSH Supplementary Concept]
- lu AE43936 [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, adrenergic, alpha-1 [MeSH Descriptor]
Record concept(s)
- adrenergic alpha-1 receptor antagonists [MeSH concept]
See also (suggested by CISMeF)
- receptors, adrenergic, alpha-1 [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-(2-(n-4-o-methoxyphenyl-N-1-piperazinyl)ethyl)-1-tetralone [MeSH Supplementary Concept]
- 2-(3-(4-(2-isopropoxyphenyl)piperazin-1-yl)propyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione [MeSH Supplementary Concept]
- 2-(3-fluorophenyl)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide [MeSH Supplementary Concept]
- 2-(4-methylphenyll)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide [MeSH Supplementary Concept]
- 4-(2-(2-methoxyphenoxy)ethylaminomethyl)-2,2-diphenyl(1,3)dioxolane [MeSH Supplementary Concept]
- 4-(2-phenoxyethylaminomethyl)-2,2-diphenyl(1,3)dioxolane [MeSH Supplementary Concept]
- 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-(4-(morpholinocarbonyl)--perhydro-1,4-diazepin-1-yl)quinoline [MeSH Supplementary Concept]
- 6-(1-benzimidazolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one [MeSH Supplementary Concept]
- 6-(1-indolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one [MeSH Supplementary Concept]
- 6-(imidazolyl)-2-((4-(2-chlorophenyl)piperazin-1-yl)heptyl)pyridazin-3(2H)-one [MeSH Supplementary Concept]
- 8-((4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)decane-7,9-dione [MeSH Supplementary Concept]
- 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)-1-methylethyl)-8-azaspiro(4.5)decane-7,9-dione [MeSH Supplementary Concept]
- 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)ethyl)-8-azaspiro(4.5)decane-7,9-dione [MeSH Supplementary Concept]
- 8-(2-(4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)dec-9,10-en-7-one [MeSH Supplementary Concept]
- Carvedilol [MeSH Descriptor]
- JTH 601 [MeSH Supplementary Concept]
- L 771688 [MeSH Supplementary Concept]
- N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexane carboxamide [MeSH Supplementary Concept]
- RS 100329 [MeSH Supplementary Concept]
- S 18327 [MeSH Supplementary Concept]
- Tamsulosin [MeSH Descriptor]
- Terazosin [MeSH Supplementary Concept]
- alfuzosin [MeSH Supplementary Concept]
- bucindolol [MeSH Supplementary Concept]
- bunazosin [MeSH Supplementary Concept]
- doxazosin [MeSH Descriptor]
- ethyl 4-(3-(4-(2-methoxyphenyl)piperazinyl)propyl)aminoquinazolin-2-carboxylate [MeSH Supplementary Concept]
- indoramin [MeSH Descriptor]
- labetalol [MeSH Descriptor]
- prazosin [MeSH Descriptor]
- silodosin [MeSH Supplementary Concept]
- trimazosin [MeSH Supplementary Concept]
- urapidil [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing alpha-1 adrenergic receptor antagonist (product) [SNOMED CT concept]
- Substance with alpha-1 adrenergic receptor antagonist mechanism of action (substance) [SNOMED CT concept]
- alpha 1 adrenergic blocking agent, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients